Literature DB >> 7261334

Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems.

E A Robertson, M H Zweig.   

Abstract

The usefulness of an analytical system in patient care is ultimately judged not by its analytical performance but by its clinical performance, i.e., its ability to separate apparently similar patients into two subgroups, one of which has a particular clinically important condition and another subgroup which does not. This clinical performance can be studied with the tools of signal detectability theory, originally developed to analyze the performance of radar and data-transmission systems. Each classification made by an analytical system may be categorized as a true-positive, true-negative, false-positive, or false-negative decision. For laboratory tests the proportion of decisions in each category depends on the biological overlap between the two subgroups, the analytical performance of the system, and the decision level chosen. The clinical performance of the analytical system for all possible decision levels is represented by the receiver operating characteristic curve, which plots the true-positive rate against the false-positive rate. The use of these curves permits comparison of alternative analytical techniques at equal true-positive rates and at all possible decision levels. These comparisons show the effect of analytical improvements on clinical performance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7261334

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  21 in total

1.  Immunosuppression in patients with severe acute pancreatitis.

Authors:  Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Makoto Shinzeki; Hidehiro Sawa; Takahiro Nakajima; Tetsuo Ajiki; Yasuhiro Fujino; Yasuyuki Suzuki; Yoshikazu Kuroda
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

2.  Utility of the new Japanese severity score and indications for special therapies in acute pancreatitis.

Authors:  Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Keiko Kamei; Shumpei Satoi; Hidehiro Sawa; Makoto Shinzeki; Yonson Ku; Yoshikazu Kuroda; Harumasa Ohyanagi
Journal:  J Gastroenterol       Date:  2009-03-25       Impact factor: 7.527

3.  Biochemical models as early predictors of the etiology of acute pancreatitis.

Authors:  D C Sadowski; J K Todd; L R Sutherland
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

4.  C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection.

Authors:  Yuji Shishido; Kazumasa Fujitani; Kazuyoshi Yamamoto; Motohiro Hirao; Toshimasa Tsujinaka; Mitsugu Sekimoto
Journal:  Gastric Cancer       Date:  2015-01-06       Impact factor: 7.370

5.  Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis.

Authors:  R Pezzilli; G V Melzi d'Eril; A M Morselli-Labate; G Merlini; B Barakat; T Bosoni
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

6.  Accuracy of sperm characteristics in predicting the in vitro fertilizing capacity of semen.

Authors:  F H Comhaire; L Vermeulen; A Hinting; F Schoonjans
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-12

7.  A fuzzy system for helping medical diagnosis of malformations of cortical development.

Authors:  Silvia Alayón; Richard Robertson; Simon K Warfield; Juan Ruiz-Alzola
Journal:  J Biomed Inform       Date:  2006-11-18       Impact factor: 6.317

8.  [Does measuring axillo-rectal temperature difference help in the diagnosis of acute appendicitis?].

Authors:  H Putzki; B Reichert
Journal:  Langenbecks Arch Chir       Date:  1988

9.  Pancreatic function testing: serum PABA measurement is a reliable and accurate measurement of exocrine function.

Authors:  A R Tanner; D P Robinson
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

10.  C-reactive protein as an indicator of resolution of sepsis in the intensive care unit.

Authors:  S M Yentis; N Soni; J Sheldon
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.